The value of natriuretic peptide testing for the diagnosis and prevention of heart failure in high-risk populations.

Gruson, Damien
(2024) Advances in laboratory medicine — Vol. 5, n° 3, p. 231-232 (2024)

Files

2024_Gruson_Adv_Lab_Med_ENG.pdf
  • Open Access
  • Adobe PDF
  • 520.33 KB
  • https://creativecommons.org/licenses/by/4.0/
Download

Details

Authors
Abstract
Heart failure (HF) represents a significant global health challenge, particularly in high-risk populations such as those with diabetes mellitus, hypertension, and cardiovascular diseases. Early diagnosis and prevention are crucial to mitigating the morbidity and mortality associated with HF. Natriuretic peptides, specifically B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP), have emerged as valuable biomarkers in the diagnosis and management of HF. This editorial explores the value of natriuretic peptide testing in high-risk populations for the early diagnosis and prevention of heart failure. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Gruson, D. (2024). The value of natriuretic peptide testing for the diagnosis and prevention of heart failure in high-risk populations. Advances in laboratory medicine, 5(3), 231-232. https://doi.org/10.1515/almed-2024-0121 (Original work published 2024)